- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ACP-196 (acalabrutinib)
Total 8068 results
-
AstraZenecaParexelCompletedCOVID-19 | Mantle Cell LymphomaGermany
-
Baker Heart and Diabetes InstituteCompletedDiabetic NephropathiesAustralia
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter SyndromeUnited States
-
Acerta Pharma BVCompletedHealthy VolunteersUnited States
-
Acerta Pharma BVAstraZenecaCompletedHepatic Insufficiency | Healthy Subjects | Hepatic ImpairmentUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Brii Biosciences LimitedTSB Therapeutics (Beijing) CO.LTDCompleted
-
Brii Biosciences LimitedTSB Therapeutics (Beijing) CO.LTDCompleted
-
Brii Biosciences, Inc.Withdrawn
-
Acerta Pharma BVAstraZenecaActive, not recruitingMantle Cell Lymphoma (MCL)United States, Poland, Italy
-
AstraZenecaCompletedBioequivalenceUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
Seoul National University HospitalNational Evidence-Based Healthcare Collaborating Agency; National Clinical... and other collaboratorsCompletedHealthyKorea, Republic of
-
AstraZenecaCompletedChronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell LymphomaIndia
-
Fuji Yakuhin Co., Ltd.Completed
-
Weill Medical College of Cornell UniversityAstraZeneca; Celgene CorporationActive, not recruitingMantle Cell LymphomaUnited States
-
PETHEMA FoundationActive, not recruitingChronic Lymphocytic Leukemia- Binet Staging SystemSpain
-
Acerta Pharma BVCompletedHealthy ParticipantsUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandRecruitingCLL/SLLNetherlands, Belgium, Denmark
-
Acerta Pharma BVAstraZenecaActive, not recruitingLymphoma, Mantle CellUnited States, France, Italy, Taiwan, Mexico, Russian Federation, Vietnam, Belgium, Canada, Brazil, Hungary, Japan, Poland, China, Spain, Germany, Australia, Czechia, Korea, Republic of, Israel, Romania, Ukraine, Argentina, Peru, New Zealand and more
-
University of MiamiAstraZenecaTerminatedMarginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Small Lymphocytic LeukemiaUnited States
-
Mayur NarkhedeADC Therapeutics S.A.RecruitingChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingMantle Cell LymphomaUnited States
-
Austin I KimAstraZeneca; Genentech, Inc.Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGrade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage...United States
-
AstraZenecaActive, not recruitingPhase I: Relapsed or Refractory B-cell Malignancies | Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma | Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic LeukemiaChina
-
Universität des SaarlandesAstraZeneca; University of Leipzig; Wuerzburg University Hospital; University Hospital... and other collaboratorsRecruitingDiffuse Large B Cell Lymphoma | Large B-cell LymphomaGermany
-
Groupe Hospitalier Paris Saint JosephObvioHealthCompleted
-
AstraZenecaAcerta Pharma BVCompleted
-
AstraZenecaYgheaRecruitingChronic Lymphocytic LeukemiaItaly
-
The Hong Kong Polytechnic UniversityTuen Mun HospitalRecruitingCoronary Heart DiseaseHong Kong
-
Swiss Group for Clinical Cancer ResearchRecruitingDiffuse Large B-cell LymphomaSwitzerland, Italy
-
AstraZenecaAcerta Pharma BVCompletedCOVID-19Italy, Turkey, Brazil, Japan, South Africa, Germany, Poland, Russian Federation, India, Peru, France, Argentina, Chile, Mexico
-
Acerta Pharma BVWithdrawn
-
TG Therapeutics, Inc.Terminated
-
Utah State UniversityCompletedGeneralized Anxiety DisorderUnited States
-
University of Alabama at BirminghamNot yet recruiting
-
AstraZenecaUKCLL ForumRecruitingChronic Lymphocytic Leukemia, CLLUnited Kingdom
-
Dana-Farber Cancer InstituteRecruitingRefractory Central Nervous System Lymphoma | Central Nervous System Lymphoma | Recurrent Central Nervous System LymphomaUnited States
-
Acerta Pharma BVAstraZenecaTerminated
-
Hospital Universitari de BellvitgeCompletedLow Rectal Adenocarcinoma
-
Fusion Pharmaceuticals Inc.TerminatedBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma | Liver Cancer | Bladder Carcinoma | Susceptible FGFR3 Genetic Alterations | FGFR3 | FGFR3 Overexpression | FGFR3 Receptor | FGFR3 Protein OverexpressionUnited States, Australia
-
Johns Hopkins UniversityAstraZenecaCompleted
-
Polish Lymphoma Research GroupAstraZenecaActive, not recruitingMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Adverse Event | Chronic Graft-versus-host-disease | Response RatePoland
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingMarginal Zone LymphomaItaly, Switzerland, Austria
-
The Hong Kong Polytechnic UniversityUnited Christian Hospital; Shatin Hospital; Bradbury HospiceRecruiting
-
University Health Network, TorontoActive, not recruiting
-
Fred Hutchinson Cancer CenterNational Institute on Drug Abuse (NIDA)CompletedNicotine Dependence | Nicotine Use Disorder | Nicotine Vaping | Vaping | Nicotine AddictionUnited States
-
Duke-NUS Graduate Medical SchoolSingapore General Hospital; National Heart Centre SingaporeCompletedHeart FailureSingapore